Kineta Inc (KA)

A look at KA's current quarter earnings estimates – US Post News - US Post News

US Post News

Kineta Inc Inc. (KA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

The InvestChronicle

KA Shares Experience Surge in Value – Knox Daily - Knox Daily

Knox Daily

KA’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

The InvestChronicle

Quarterly Metrics: Quick and Current Ratios for Kineta Inc (KA) – DWinneX - The Dwinnex

The Dwinnex

Kineta reports progress in cancer therapy trials By Investing.com - Investing.com

Investing.com

Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical ... - wallstreet:online

wallstreet:online

Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical ... - wallstreet:online

wallstreet:online

Kineta: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

BioWorld Cancer Index ends Q1 up on pipeline progress, despite restructurings - BioWorld Online

BioWorld Online

Kineta (NASDAQ:KA) Stock Price Down 7.4% - Defense World

Defense World

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Adaptive ... - Benzinga

Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In ... - Markets Insider

Markets Insider

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day ... - Markets Insider

Markets Insider

Kineta Reports Progress in KVA12123 Cancer Trial - TipRanks.com - TipRanks

TipRanks

Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial

GlobeNewswire Inc.

Kineta reports positive trial results for cancer therapy By Investing.com - Investing.com

Investing.com

Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

KA Stock Quote Price and Forecast - CNN

CNN

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day ... - Markets Insider

Markets Insider

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday’s Mid-D - Benzinga

Benzinga

S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results

Benzinga

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings

Benzinga

Kineta Weighs Strategic Alternatives Amid Operational Challenges - TipRanks.com - TipRanks

TipRanks

Seattle biotech company Kineta lays off majority of staff, including its CEO - GeekWire

GeekWire

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium

GlobeNewswire Inc.

Kineta to Present at Upcoming Investor Conferences

GlobeNewswire Inc.

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

GlobeNewswire Inc.

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

GlobeNewswire Inc.

KA: Autumn Activity - Yahoo Finance

Yahoo Finance

Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc - Yahoo Finance

Yahoo Finance

Seattle biotech firm Kineta averts Nasdaq stock delisting - Puget Sound Business Journal - The Business Journals

The Business Journals

Selection waits on efficacy data from trial of Kv1.3 ion channel blocker in atopic dermatitis - BioWorld Online

BioWorld Online

Kineta Stock (NASDAQ:KA), Quotes and News Summary - Benzinga

Benzinga

Merck Officially Commences $1.36B Imago Buyout - BioSpace

BioSpace

Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger ... - GlobeNewswire

GlobeNewswire

Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda - BioSpace

BioSpace

Yumanity selling neurology assets and merging with Kineta - Labiotech.eu

Labiotech.eu

Aslan, Yumanity, Editas, Janssen and More Team Up to Fight Disease - BioSpace

BioSpace

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions - GlobeNewswire

GlobeNewswire

Kineta Presenting in Multiple Sessions at the Preclinical Immuno-oncology Online 2022 - PR Newswire

PR Newswire

Kineta to Present Poster on Anti-CD27 Agonist Antibody Program at the AACR Annual Meeting 2022 - PR Newswire

PR Newswire

Kineta Announces Patent Issuance for U.S. Patent Covering Composition of Matter of KCP506, a Novel Non-opioid ... - PR Newswire

PR Newswire